Sigma’s undertaking boosts market confidence, oral medication for T2D in children approved, mpox vaccinations reminder, Haleon fellowship, and more
Click here to download Pharmacy Daily for Friday 4th October 2024
PARTNER SITES
Other recent headlines
-
Sigma’s share price rally
Friday | Oct 4 2024SIGMA Healthcare Limited’s share price has surged this week, reaching $2.06, up from $1.46 seven days ago.
-
Oral drug for kids with T2D
Friday | Oct 4 2024JARDIANCE (empagliflozin) has become the first oral treatment to be available on private script for type 2 diabetes (T2D) in children and adolescents, since metformin was indicated for use in this growing patient group.
-
Priceline’s rebrand “a real refresh”
Thursday | Oct 3 2024PRICELINE is set to undergo a rebrand next month to reflect its strategy combining beauty with health expertise and value.
to top